The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Withdrawal risk during a recession can threaten income stability. This overview highlights risk factors and straightforward mitigation approaches.
26,857 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Bitcoin, Ethereum, and XRP led a weekend comeback, lifting the total crypto market cap and centering attention on a p...
As clean energy climbs, storage plays a pivotal role. This article breaks down why energy stock soaring today points ...
Institutional moves shape the AI stock landscape. This article dives into Philippe Laffont’s Coatue strategy, why Nvi...
Oil spikes can move markets quickly, pushing indexes lower. Yet even with a sharp price surge, the selloff often rema...
In a choppy 2026 market, Cathie Wood isn’t chasing high-flying tech alone. She’s quietly adding to positions in three...
After a string of near-misses, Netflix finally makes acquisition that seems to align with its long-term plan. This pi...
As orthofix prepares its 2025 earnings narrative, investors weigh product mix shifts, margins, and macro headwinds. T...
ZIM shares hover near $27.54, well under Hapag-Lloyd’s $35 cash proposal. The discount reflects regulatory risk aroun...
A high-profile courtroom moment becomes a real-world lesson in protecting your finances. Learn how to safeguard asset...
Chainlink unveils Project Pangea to pilot same-day FX settlement using fiat backed stablecoins, potentially freeing u...
Morgan Stanley signals a landmark shift by planning direct Bitcoin custody and trading within its platform, edging cr...